Inhibitory effects of trientine, a copper-chelating agent, on induction of DNA strand breaks in kidney cells of Long-Evans Cinnamon (LEC) rats
- PMID: 16365517
- DOI: 10.1538/expanim.54.403
Inhibitory effects of trientine, a copper-chelating agent, on induction of DNA strand breaks in kidney cells of Long-Evans Cinnamon (LEC) rats
Abstract
The effects of treatment with trientine, a specific copper-chelating agent, on the accumulation of copper and induction of DNA strand breaks were investigated in Long-Evans Cinnamon (LEC) rats, an animal model for human Wilson's disease. Copper accumulated in the kidneys of LEC rats in an age-dependent manner from 12 to 18 weeks of age. When LEC rats were treated with trientine from 10 weeks of age, renal copper contents did not increase and were maintained at the same levels as those in 4-week-old LEC rats. Estimation of the amounts of DNA single-strand breaks (SSBs) by comet assay showed that SSBs of DNA were induced in a substantial population of LEC rat renal cortex cells around 12 weeks of age and that the amounts of SSBs increased in an age-dependent manner from 12 to 18 weeks of age. When LEC rats were treated with trientine from 10 weeks of age, the observed number of cells with DNA damage decreased, suggesting that induction of SSBs of DNA was inhibited and/or SSBs were repaired during the period of treatment with trientine. The results show that SSBs of DNA in LEC rat kidney cells are induced prior to occurrence of clinical signs of hepatic injury and that treatment of LEC rats with trientine decreases the number of DNA strand breaks.
Similar articles
-
Inhibitory effects of trientine, a copper-chelating agent, on induction of DNA strand breaks in hepatic cells of Long-Evans Cinnamon rats.Biochim Biophys Acta. 2004 Nov 1;1674(3):312-8. doi: 10.1016/j.bbagen.2004.07.006. Biochim Biophys Acta. 2004. PMID: 15541301
-
Accumulation of copper induces DNA strand breaks in brain cells of Long-Evans Cinnamon (LEC) rats, an animal model for human Wilson Disease.Exp Anim. 2006 Oct;55(5):419-26. doi: 10.1538/expanim.55.419. Exp Anim. 2006. PMID: 17090957
-
Inhibition of hereditary hepatitis and liver tumor development in Long-Evans cinnamon rats by the copper-chelating agent trientine dihydrochloride.Hepatology. 1996 Apr;23(4):764-70. doi: 10.1053/jhep.1996.v23.pm0008666330. Hepatology. 1996. PMID: 8666330
-
Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.Drugs. 2011 Jul 9;71(10):1281-320. doi: 10.2165/11591370-000000000-00000. Drugs. 2011. PMID: 21770477 Review.
-
Role of Trientine in Hypertrophic Cardiomyopathy: A Review of Mechanistic Aspects.Pharmaceuticals (Basel). 2022 Sep 14;15(9):1145. doi: 10.3390/ph15091145. Pharmaceuticals (Basel). 2022. PMID: 36145368 Free PMC article. Review.
Cited by
-
Construction of a Novel circRNA/miRNA/mRNA Regulatory Network to Explore the Potential Pathogenesis of Wilson's Disease.Front Pharmacol. 2022 Jun 15;13:905513. doi: 10.3389/fphar.2022.905513. eCollection 2022. Front Pharmacol. 2022. PMID: 35784724 Free PMC article.
-
Animal models of Wilson disease.J Neurochem. 2018 Aug;146(4):356-373. doi: 10.1111/jnc.14323. Epub 2018 Jun 26. J Neurochem. 2018. PMID: 29473169 Free PMC article. Review.
-
A copper(II)-selective chelator ameliorates diabetes-evoked renal fibrosis and albuminuria, and suppresses pathogenic TGF-beta activation in the kidneys of rats used as a model of diabetes.Diabetologia. 2008 Sep;51(9):1741-51. doi: 10.1007/s00125-008-1088-7. Epub 2008 Jul 18. Diabetologia. 2008. PMID: 18636238
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
